Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
214 participants
OBSERVATIONAL
2021-06-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Open Versus Endovascular Repair of Abdominal Aortic Aneurysms
NCT04068714
Efficacy of Biomarkers and CEUS Versus CTA in AAA Follow-up Post-EVAR
NCT06866769
Immediate Management of the Patient With Rupture : Open Versus Endovascular Repair
NCT00746122
Elective Abdominal Aortic Aneurism - Open Versus Endovascular Repair
NCT00224718
EndoVascular Aortic Repair With Sac Embolization for the Prevention of Type II Endoleaks (the EVAR-SE Study)
NCT05665101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients that had secondary interventions after EVAR
EVAR
Endovascular repair of abdominal aortic aneurysms
Patients without secondary interventions after EVAR
EVAR
Endovascular repair of abdominal aortic aneurysms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EVAR
Endovascular repair of abdominal aortic aneurysms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Sao Joao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marina Felicidade Dias Neto
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marina Felicidade Dias Neto
Porto, State/Province, Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10353
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.